OncoMatch/Clinical Trials/NCT07638774
The Efficacy of Compression/Ice Gloves/Socks in Patients With UTD1-induced Neuropathy.
Is NCT07638774 recruiting? Yes, currently enrolling (Jul 2026). This NA trial studies multiple treatments including compression glove/sock and ice glove/sock for locally advanced or metastatic breast cancer.
Treatment: compression glove/sock · ice glove/sock — This study is a prospective, multicenter, phase Ⅲ trial to evaluate of the compression/ice gloves/socks efficacy in UTD1-induced peripheral sensory and motor neuropathy. 324 patients will be included. All patients will be randomly divided into three groups at a ratio of 1:1:1. Group A is the blank control group, group B is the compression glove/sock group, and group C is the ice glove/sock group.
Check if I qualifyExtracted eligibility criteria
Treatments studied
Other
Cancer type
Breast Carcinoma
Performance status
ECOG 0–1(Restricted strenuous activity)
Demographics
Prior therapy
Cannot have received: utd1
Lab requirements
Blood counts
ANC ≥1,500/mm3; WBC ≥3.5×10^9/L; platelets ≥75,000/mm3; hemoglobin ≥9 g/dL; no blood transfusion and blood products within 14 days; no G-CSF and other hematopoietic stimulation factor within 7 days
Kidney function
Serum creatinine ≤1.5 × ULN
Liver function
AST, ALT, ALP ≤ 2.5 × ULN when no liver metastasis; ≤ 5 × ULN when liver metastasis
Adequate organ and bone marrow function defined as follows within 7 days before enrollment: ANC ≥1,500/mm3, WBC ≥3.5×10^9/L, platelets ≥75,000/mm3, hemoglobin ≥9 g/dL, no blood transfusion and blood products within 14 days, no G-CSF and other hematopoietic stimulation factor within 7 days. Serum creatinine ≤1.5 × ULN; AST, ALT, ALP ≤ 2.5 × ULN when no liver metastasis; ≤ 5 × ULN when liver metastasis.
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT07638774 currently recruiting?
Yes, this trial is currently recruiting patients.
Are there prior therapy exclusions?
Yes. Prior utd1 disqualifies patients from enrollment.
Is there an age limit?
Yes. Patients must be 75 years or younger.
Is this trial open to male patients?
No. This trial enrolls female patients only.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages